Pancreatic Cancer Research

ResearcherNational Institutes of HealthNo recent work listed

Udo Rudloff

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2137-9040; OpenAlex author ID A5028439777. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
44
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper

Papers 12

  1. Emerging kinase inhibitors for the treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/14728214.2022.2134346↗
  2. Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRAS G12R-mutant pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s10637-020-01044-8↗
  3. T Cell-Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic Canc… Last author DOI 10.1158/1535-7163.mct-20-0620↗
  4. Atypical KRAS G12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-19-1006↗
  5. Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-Kras G12D/+;Tp53R172H/+ (KPC) mice, a genetically engineered model… Last author DOI 10.1007/s00280-018-3699-0↗
  6. Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells. Last author DOI 10.1186/s12885-018-4690-1↗
  7. Expression of the scaffold connector enhancer of kinase suppressor of Ras 1 (CNKSR1) is correlated with clinical outcome in pancreatic cancer. Last author DOI 10.1186/s12885-017-3481-4↗
  8. Whole Genome Sequencing of Newly Established Pancreatic Cancer Lines Identifies Novel Somatic Mutation (c.2587G>A) in Axon Guidance Receptor Plexin A1 as Enhan… Last author DOI 10.1371/journal.pone.0149833↗
  9. Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular i… Last author DOI 10.1007/s10637-014-0157-7↗
  10. A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer. Co-author DOI 10.1089/hum.2013.209↗
  11. An integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancer. Co-author DOI 10.1186/1755-8794-6-33↗
  12. Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating cells. Co-author DOI 10.1016/j.scr.2012.08.001↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dandan Li · 3 shared papers, 2018–2021 · strength 0.24
  2. Yaroslav Teper · 3 shared papers, 2014–2021 · strength 0.19
  3. Itzhak Avital · 3 shared papers, 2012–2018 · strength 0.16
  4. Rebecca A. Sorber · 2 shared papers, 2016–2021 · strength 0.15
  5. Cara M. Kenney · 1 shared paper, 2021 · strength 0.13
  6. Niharika B. Mettu · 1 shared paper, 2021 · strength 0.13
  7. Edward Jae-Hoon Kim · 1 shared paper, 2021 · strength 0.13
  8. Tashinga E. Bapiro · 1 shared paper, 2021 · strength 0.10
  9. Frances M. Richards · 1 shared paper, 2021 · strength 0.10
  10. Duncan Ian Jodrell · 1 shared paper, 2021 · strength 0.10
  11. John E. Mullinax · 1 shared paper, 2018 · strength 0.08
  12. Jonathan M. DeLiberty · 1 shared paper, 2020 · strength 0.08
  13. Bjoern Papke · 1 shared paper, 2020 · strength 0.08
  14. Emanuel F. Petricoin · 1 shared paper, 2020 · strength 0.08
  15. J. Nathaniel Diehl · 1 shared paper, 2020 · strength 0.08
  16. Mariaelena Pierobon · 1 shared paper, 2020 · strength 0.08
  17. Kirsten L. Bryant · 1 shared paper, 2020 · strength 0.08
  18. Adrienne D. Cox · 1 shared paper, 2020 · strength 0.08
  19. Jennifer E. Klomp · 1 shared paper, 2020 · strength 0.08
  20. Andrew J. Aguirre · 1 shared paper, 2020 · strength 0.08
  21. Andrew M. Waters · 1 shared paper, 2020 · strength 0.08
  22. Brian Matthew Wolpin · 1 shared paper, 2020 · strength 0.08
  23. Channing J. Der · 1 shared paper, 2020 · strength 0.08
  24. G. Aaron Hobbs · 1 shared paper, 2020 · strength 0.08
  25. Nicole Marie Baker · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.